Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).
Diabetes Metab J
; 45(4): 615-616, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1362651
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Dipeptidyl-Peptidase IV Inhibitors
/
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Diabetes Metab J
Year:
2021
Document Type:
Article
Affiliation country:
Dmj.2021.0081
Similar
MEDLINE
...
LILACS
LIS